1. Hepatitis delta infection among persons living with HIV in Europe. Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G; EuroSIDA and SHCS.
   Liver Int. 2023;43(4):819-828. Abstract
    
2. Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients. Nørgaard JC, Jørgensen M, Moestrup KS, Ilett EE, Zucco AG, Marandi RZ, Julian MN, Paredes R, Lundgren JD, Sengeløv H, MacPherson C.
   J Infect Dis. 2023:jiad033. Epub ahead of print. Abstract
    
3. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Surial B, Mena AR, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
   J Hepatol. 2023:S0168-8278(23)00011-9. Epub ahead of print.Abstract
    
4. Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load. Gabrielaite M, Bennedbæk M, Rasmussen MS, Kan V, Furrer H, Flisiak R, Losso M, Lundgren JD; INSIGHT START Study Group; Marvig RL.
   PLoS Comput Biol. 2023;19(1):e1010756. Abstract
    
5. Development of a machine learning model for early prediction of plasma leakage in suspected dengue patients. Zargari Marandi R, Leung P, Sigera C, Murray DD, Weeratunga P, Fernando D, Rodrigo C, Rajapakse S, MacPherson CR.
   PLoS Negl Trop Dis. 2023;17(3):e0010758. Abstract
    
6. Superinfections in COVID-19 patients receiving extracorporeal membrane oxygenation support. V Andersen H, Jørgensen VRL, Steensen M, Pedersen FM, Helleberg M.
   Acta Anaesthesiol Scand. 2023. Epub ahead of print. Abstract
    
7. Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study. Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem VN, Günthard HF, Zangerle R, Smith C, Castagna A, D Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group.
   Clin Infect Dis. 2023:ciad219. Epub ahead of print. Abstract
    
8. Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Lundgren JD, Babiker AG, Sharma S, Grund B, Phillips AN, Matthews G, Kan VL, Aagaard B, Abo I, Alston B, Arenas-Pinto A, Avihingsanona, Badal-Faesen S, Brites C, Carey C, Casseb J, Clarke A, Collins S, Corbelli GM, Dao S, Denning ET, Emery S, Eriobu N, Florence E, Furrer H, Fätkenheuer G, Gerstoft J, Gisslen M, Goodall K, Henry K, Horban A, Hoy J, Hudson F, Azwa RISR, Kedem E, Kelleher A, Kityo C, Klingman K, La Rosa A, Leturque N, Lifson AR, Losso M, Lutaakome J, Sierra Madero J, Mallon P, Mansinho K, Marhoum El Filali K, Molina JM, Murray DD, Nagalingeswaran K, Nozza S, Ormaasen V, Paredes R, Peireira LC, Pillay S, Polizzotto MN, Raben D, Rieger A, Sanchez A, Schechter M, Sedlacek D, Staub T, TouloumiG, Turner M, Valdez Madruga J, Vjecha M, Wolff M, Wood R, Zilmer K, Lane C, Neaton JD
   NEJM Evid 2023; 2 (3). Abstract
    
9. Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality. Terrones-Campos C, Ledergerber B, Forbes N, Smith AG, Petersen J, Helleberg M, Lundgren J, Specht L, Vogelius IR.
   Clin Oncol (R Coll Radiol). 2023:S0936-6555(23)00150-4. Epub ahead of print. Abstract
    
10. Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE). Bannister WP, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, Brouw Iversen M, Schmeltz Søgaard O, Rye Ostrowski S, Breinholt Stærke N, Jakobsen ML, Olaf Lindvig S, Ruwald Juhl M, Somuncu Johansen I, Mustafa AB, Østergaard L, Dam Larsen F, Surland Knudsen L, Klastrup V, Wiese L, Benfield T, Toft Petersen K, Iversen KK, Nielsen H, Reekie J, Lundgren J; ENFORCE Study Group.
    Open Forum Infect Dis. 2023;10(6):ofad248. Abstract
     
11. Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, on behalf of the RESPOND and D:A:D Study Groups
    Cancers. 2023. Jul 15;15(14):3640 Epub ahead of print. Abstract
     
12. Long-term outcomes after tuberculosis for people with HIV in eastern Europe. Kraef C, Bentzon A, Roen A, Bolokadze N, Thompson M, Azina I,; Tetradov S, Skrahina A, Karpov I, Mitsura V, Paduto D, Trofimova T, Borodulina E, Mocroft A, Kirk O, Podlekareva D.
    AIDS 2023. Abstract
     
13. Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort. Fursa O, Reekie J, Kuzin I, Hetman L, Kryshchuk A, Starychenko O, Hrytsaiuk N, Khodus I, Nyzhnyk A, Rakhuba V, Kovalevska M, Maistat T, Pryhoda I, Ahieieva M, Varvarovska O, Valdenmaiier O, Lundgren J, Peters L; CARE study group.
    J Int AIDS Soc. 2023;26(9):e26166. Abstract
     
14. Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity. Dietz LL, Juhl AK, Søgaard OS, Reekie J, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Jensen TØ, Jakobsen SF, Olesen R, Iversen K, Fogh K, Bodilsen J, Petersen KT, Larsen L, Madsen LW, Lindvig SO, Holden IK, Raben D, Andersen SD, Hvidt AK, Andreasen SR, Baerends EAM, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
    Commun Med (Lond). 20234;3(1):58. Abstract
     
15. Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study. Baerends EAM, Reekie J, Andreasen SR, Stærke NB, Raben D, Nielsen H, Petersen KT, Johansen IS, Lindvig SO, Madsen LW, Wiese L, Iversen MB, Benfield T, Iversen KK, Larsen FD, Andersen SD, Juhl AK, Dietz LL, Hvidt AK, Ostrowski SR, Krause TG, Østergaard L, Søgaard OS, Lundgren J, Tolstrup M.
    Clin Infect Dis. 2023:ciad402. Abstract
     
16. Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection. Rasmussen KK, Dos Santos Q, MacPherson CR, Zucco AG, Gjærde LK, Ilett EE, Lodding I, Helleberg M, Lundgren JD, Nielsen SD, Brix S, Sengeløv H, Murray DD.
    Metabolites. 2023;13(9):968. Abstract
     
17. Heavy arv exposure and exhausted/limited arv options: predictors and clinical outcomes. Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, Domingo P, Rasmussen LD, Günthard HF, Surial B, Öllinger A, Knappik M, De Wit S, Wit F, Mussini C, Vehreschild J, Monforte AD, Sonnerborg A, Castagna A, Anne AV, Vannappagari V, Cohen C, Greaves W, Wasmuth JC, Spagnuolo V, Ryom L; RESPOND cohort collaboration.
    AIDS. 2023. Epub ahead of print. Abstract
     
18. Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply. Neesgaard B, Greenberg L, Peters L, Mocroft A, Ryom L; writing group and the RESPOND study group.
    Lancet HIV. 2023;10(1):e9-e10. Abstract
     
19. An opinion piece on how we move towards common European standards of care for people with HIV. Rockstroh J, Laut KG, Jakobsen SF, Raben D, Verluyten J, Behrens G, Martinez E, Noori T, Pharris A, Simões D, Sullivan A.
    AIDS. 2023;37(13):1941-1948. Abstract
     
20. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study. Schwenke JM, Thorball CW, Schoepf IC, Ryom L, Hasse B, Lamy O, Calmy A, Wandeler G, Marzolini C, Kahlert CR, Bernasconi E, Kouyos RD, Günthard HF, Ledergerber B, Fellay J, Burkhalter F, Tarr PE; Swiss HIV Cohort Study.
    J Infect Dis. 2023;228(6):742-750. Abstract
     
21. Associations between invasive aspergillosis and cytomegalovirus in lung transplant recipients: a nationwide cohort study. Wulff SM, Perch M, Helweg-Larsen J, Bredahl P, Arendrup MC, Lundgren J, Helleberg M, Crone CG.
    APMIS. 2023;131(11):574-583. Abstract
     
22. Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort. Zucco AG, Bennedbæk M, Ekenberg C, Gabrielaite M, Leung P, Polizzotto MN, Kan V, Murray DD, Lundgren JD, MacPherson CR; INSIGHT START study group.
    AIDS. 2023;37(11):1643-1650. Abstract
     
23. Clonal hematopoiesis of indeterminate potential in Persons living with HIV. Knudsen AD, Eskelund CW, Benfield T, Zhao Y, Gelpi M, Køber L, Trøseid M, Kofoed KF, Ostrowski SR, Reilly C, Borges ÁH, Grønbæk K, Nielsen SD.
    AIDS. 2023. Epub ahead of print. Abstract
     
24. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID-19. Grønbaek KK, Rasmussen SM, Langer NH, Vincentz M, Oxbøll AB, Søgaard M, Awada HN, Jensen TO, Jensen MT, Sørensen HBD, Aasvang EK, Meyhoff CS.
    Acta Anaesthesiol Scand. 2023;67(5):640-648. Abstract
     
25. C-reactive protein and procalcitonin use in adults in low- and middle-income countries: a narrative review. Lamrous A, Repetto E, Depp T, Jimenez C, Chua AC, Kanapathipillai R, Jensen TO.
    AC Antimicrob Resist. 2023;5(3):dlad057. Abstract
     
26. Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation. Minculescu L, Reekie J, Petersen SL, Kornblit BT, Schjoedt I, Andersen NS, Andersen LP, Fischer-Nielsen A, Haastrup EK, Friis LS, Sengelov H.
    Acta Haematol. 20235. Epub ahead of print. Abstract
     
27. Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. Ingle SM, Miro JM, May MT, Cain LE, Schwimmer C, Zangerle R, Sambatakou H, Cazanave C, Reiss P, Brandes V, Bucher HC, Sabin C, Vidal F, Obel N, Mocroft A, Wittkop L, d'Arminio Monforte A, Torti C, Mussini C, Furrer H, Konopnicki D, Teira R, Saag MS, Crane HM, Moore RD, Jacobson JM, Mathews WC, Geng E, Eron JJ, Althoff KN, Kroch A, Lang R, Gill MJ, Sterne JAC.
    Clin Infect Dis. 2023;77(1):64-73. Abstract
     
28. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group.
    J Infect Dis. 2023:jiad446. Abstract
     
29. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit. Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Simon PV, Carcas-Sansuan AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken AJ, Di Marzo R, Luís C, Olesen OF, Frias Iniesta JA, Barta I, Tóth K, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Armeftis C, Marques L, Naucler P, Ochando J, Tacconelli E, van Damme P, Zaoutis T, Hofstraat S, Bruijning-Verhagen P, Zeitlinger M, Cornely OA, Pana ZD.
    JMIR Public Health Surveill. 2023;9:e44491. Abstract
     
30. Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark. Rasmussen LD, Lebech AM, Øvrehus A, Poulsen BK, Christensen HR, Nielsen H, Johansen IS, Omland LH, Wiese L, Helleberg M, Storgaard M, Dalager-Pedersen M, Rasmussen TA, Benfield T, Petersen TS, Andersen ÅB, Gram MA, Stegger M, Edslev SM, Obel N.
    Br J Clin Pharmacol. 2023;89(6):1820-1833. Abstract
     
31. Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study. Thudium RF, Ronit A, Afzal S, Çolak Y, Forman JL, Mendo F, Chen F, Estrada V, Kumarasamy N, Nordestgaard BG, Lundgren J, Vestbo J, Kunisaki KM, Nielsen SD; COCOMO, INSIGHT START Pulmonary Substudy and CGPS Study Groups.
    Thorax. 2023;78(6):535-542. Abstract
     
32. Fighting cervical cancer in Africa: a cross-sectional study on prevalence and risk factors for precancerous lesions in rural Uganda. Christensen AJ, Mwayi J, Mbabazi J, Juncker M, Kallestrup P, Kraef C.
    Public Health. 2023;225:87-95. Abstract
     
33. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. Brown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID, Lanspa M, Gilstrap DL, Mourad A, Lane K, Beitler JR, Serra AL, Garcia I, Almasri E, Fayed M, Hubel K, Harris ES, Middleton EA, Barrios MAG, Mathews KS, Goel NN, Acquah S, Mosier J, Hypes C, Salvagio Campbell E, Khan A, Hough CL, Wilson JG, Levitt JE, Duggal A, Dugar S, Goodwin AJ, Terry C, Chen P, Torbati S, Iyer N, Sandkovsky US, Johnson NJ, Robinson BRH, Matthay MA, Aggarwal NR, Douglas IS, Casey JD, Hache-Marliere M, Georges Youssef J, Nkemdirim W, Leshnower B, Awan O, Pannu S, O'Mahony DS, Manian P, Awori Hayanga JW, Wortmann GW, Tomazini BM, Miller RF, Jensen JU, Murray DD, Bickell NA, Zatakia J, Burris S, Higgs ES, Natarajan V, Dewar RL, Schechner A, Kang N, Arenas-Pinto A, Hudson F, Ginde AA, Self WH, Rogers AJ, Oldmixon CF, Morin H, Sanchez A, Weintrob AC, Cavalcanti AB, Davis-Karim A, Engen N, Denning E, Taylor Thompson B, Gelijns AC, Kan V, Davey VJ, Lundgren JD, Babiker AG, Neaton JD, Lane HC; ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group.
    Lancet Respir Med. 2023;11(9):791-803. Abstract
     
34. Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis-A Nationwide Cohort Study. Crone CG, Wulff SM, Ledergerber B, Helweg-Larsen J, Bredahl P, Arendrup MC, Perch M, Helleberg M.
    J Fungi (Basel). 2023;9(11):1079. Abstract
     
35. Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV. Reilly CS, Borges ÁH, Baker JV, Safo SE, Sharma S, Polizzotto MN, Pankow JS, Hu X, Sherman BT, Babiker AG, Lundgren JD, Lane HC.
    J Infect Dis. 2023;227(8):951-960. Abstract
     
36. Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study. Avery EF, Kleynhans JN, Ledergerber B, Schoepf IC, Thorball CW, Kootstra NA, Reiss P, Ryom L, Braun DL, Thurnheer MC, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Kouyos RD, Fellay J, Günthard HF, Tarr PE; Swiss HIV Cohort Study.
    Clin Infect Dis. 2023;76(11):1969-1979. Abstract
     
37. Mild induced hypothermia and coagulation and platelet function in patients with septic shock: Secondary outcome of a randomized trial. Itenov TS, Kromann ME, Ostrowski SR, Bestle MH, Mohr T, Gyldensted L, Lindhardt A, Thormar K, Sessler DI, Juffermans NP, Lundgren JD, Jensen JU.
    Acta Anaesthesiol Scand. 2023;67(7):909-917. Abstract
     
38. Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection. Mikaeloff F, Gelpi M, Benfeitas R, Knudsen AD, Vestad B, Høgh J, Hov JR, Benfield T, Murray D, Giske CG, Mardinoglu A, Trøseid M, Nielsen SD, Neogi U.
    Elife. 2023;12:e82785. Abstract
     
39. Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population. Lundgren J.
    Clin Infect Dis. 2023;77(4):558-559. Abstract
     
40. Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta-analysis. Munch MW, Granholm A, Jonsson AB, Sjövall F, Helleberg M, Hertz FB, Andersen JS, Steensen M, Achiam MP, Perner A, Møller MH.
    Acta Anaesthesiol Scand. 2023;67(7):853-868. Abstract
     
41. Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis. Phillips AN, Bansi-Matharu L, Shahmanesh M, Hargreaves JR, Smith J, Revill P, Sibanda E, Ehrenkranz P, Sikwese K, Rodger A, Lundgren JD, Gilks CF, Godfrey C, Cowan F, Cambiano V.
    Lancet Glob Health. 2023;11(10):e1648-e1657. Abstract
     
42. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey. Tinggaard M, David KP, Gerstoft J, Hansen AE, Kirk O, Lebech AM, Lindhardt BØ, Rose MV, Ryom L, Weis N, Benfield T.
    HIV Med. 2023;24(1):46-54. Abstract
     
43. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin D, Jenkins S, Resar D, Amole C, Shahmanesh M, Gupta RK, Raizes E, Johnson C, Inzaule S, Shafer R, Warren M, Stansfield S, Paredes R, Phillips AN; HIV Modelling Consortium.
    Lancet HIV. 2023;10(4):e254-e265. Abstract
     
44. Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function. Møller DL, Sørensen SS, Rezahosseini O, Rasmussen DB, Arentoft NS, Loft JA, Perch M, Gustafsson F, Lundgren J, Scheike T, Knudsen JD, Ostrowski SR, Rasmussen A, Nielsen SD.
    Front Immunol. 2023;14:1183703. Abstract
     
45. Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study. Cozzi-Lepri A, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J, Baxter JD; INSIGHT START Study Group.
    HIV Med. 2023. Epub ahead of print. Abstract
     
46. Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensus. Croxford SE, Martin V, Lucas SB, Miller RF, Post FA, Anderson J, Apea VJ, Asboe D, Brough G, Chadwick DR, Collins S, Corkin H, Dean G, Delpech VC, Gogia M, Gold D, Kafkalias A, Korkodilos M, Kowalska JD, Lindo J, Lundgren JD, Lynch L, Martinez E, McDougall N, North S, Rockstroh JK, Sabin C, Vidal-Read M, Waters LJ, Sullivan AK.
    Lancet HIV. 2023;10(3):e195-e201. Abstract
     
47. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection. Baerends EAM, Hvidt AK, Reekie J, Søgaard OS, Stærke NB, Raben D, Nielsen H, Petersen KT, Juhl MR, Johansen IS, Lindvig SO, Madsen LW, Wiese L, Knudsen LS, Iversen MB, Benfield T, Iversen KK, Andersen SD, Juhl AK, Dietz LL, Andreasen SR, Fischer TK, Erikstrup C, Valentiner-Branth P, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
    iScience. 2023;26(9):107621. Abstract
     
48. Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole. Helleberg BB, Gudmundsson KSS, Kurtzhals JAL, Helleberg M.
    Lancet Infect Dis. 2023;23(11):e505. Abstract
     
49. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. Salmanton-García J, Wipfler P, Valle-Simón P, Merakou C, Kopsidas I, Bethe U, Steinbach A, Spivak O, Součková L, Mendonça MA, Koniordou M, Hellemans M, Frías-Iniesta J, Davis RJ, Barta I, Azzini AM, Askling HH, Argyropoulos CD, Álvarez-Barco E, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Flisiak R, Husa P, Jancoriene L, Koscalova A, Launay O, Lundgren J, Mallon P, Marques L, Nauclér P, Ochando J, Pana ZD, Tacconelli E, Tóth K, Trelle S, van Damme P, Zaoutis TE, Zeitlinger M, Albus K, Stewart FA, Hofstraat SHI, Bruijning-Verhagen P, Cornely OA; VACCELERATE Consortium.
    Vaccine. 2023;41(26):3915-3922. Abstract
     
50. Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. Heinz JL, Swagemakers SMA, von Hofsten J, Helleberg M, Thomsen MM, De Keukeleere K, de Boer JH, Ilginis T, Verjans GMGM, van Hagen PM, van der Spek PJ, Mogensen TH.
    Front Mol Neurosci. 2023;16:1253040. Abstract
     
51. Within-patient horizontal transfer of pOXA-48 from a hypervirulent Klebsiella pneumoniae SL218 to Serratia marcescens following spread of the K. pneumoniae isolate among hospitalised patients, Denmark, 2021. Nielsen KL, Sørensen M, Hertz FB, Misiakou MA, Hasman H, Häussler S, Helleberg M, Schønning K.
    Euro Surveill. 2023;28(17):2300196. Abstract
     
52. Measures of longitudinal immune dysfunction and risk of AIDS and non-AIDS defining malignancies in antiretroviral treated people with HIV.  Frédérique Chammartin , A. Mocroft, A. Egle, R. Zangerle, C. Smith,  C.Mussini, F. Wit, J.J. Vehrechild, A. d’Arminio Monforte, A. Castagna, L. Bailly, J. Bogner, S. de Wit, M. Raimonda, M. Law, V. Svedhem, J. Tallada, H. Garges, A. Marongiu, A. Borges, N. Jaschinski, B. Neesgaard, L. Ryom, H. C. Bucher for the RESPOND Study Group. Clinical Infectious Diseases, 2023 . Abstract
     
53. Predicting type 2 diabetes risk before and after solid organ transplantation using polygenic scores in a Danish cohort. Dos Santos Q, Leung P, Thorball CW, Ledergerber B, Fellay J, MacPherson CR, Hornum M, Terrones-Campos C, Rasmussen A, Gustafsson F, Perch M, Sørensen SS, Ekenberg C, Lundgren JD, Feldt-Rasmussen B, Reekie J.
    Front Mol Biosci. 2023;10:1282412. Abstract
     

IN PRESS

1. Association between change in body mass index and risk of hypertension and dyslipidemia in people receiving integrase inhibitors and/or tenofovir alafenamide compared to other contemporary antiretroviral regimens. Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, D’Arminio Monforte A, Mussini C, Wasmuth J-C, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K, on behalf of the RESPOND study group
   Lancet HIV, 2023.